Edgar Filing: AMERISOURCEBERGEN CORP

AMERISOURCEBERGEN CORPORATION

Date: July 12, 2007

/s/ Michael D. DiCandilo

Michael D. DiCandilo

Executive Vice President and Chief Financial Officer

Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 12, 2007

AmerisourceBergen Corporation

(Exact name of Registrant as specified in its charter)

Delaware

1-16671

23-3079390

(State or Other Jurisdiction

of Incorporation or Organization)

Commission File Number

(I.R.S. Employer

Identification Number)

1300 Morris Drive

Chesterbrook, PA

19087

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (610) 727-7000

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01.

Other Events.

On July 12, 2007, AmerisourceBergen Corporation (the “Registrant”) and Kindred Healthcare, Inc. (“Kindred”) issued a news release announcing the record date of July 20, 2007 for the spin offs of their respective institutional pharmacy businesses. The spin-offs and subsequent combination of these businesses will create PharMerica Corporation, which will be listed on the New York Stock Exchange under the symbol “PMC.” Shareholders of record of either Registrant’s or Kindred’s common stock at the end of the business day on July 20, 2007 will be entitled to receive shares of PharMerica Corporation’s common stock on July 31, 2007, the closing date for the transaction. The news release also announced the nine members of PharMerica Corporation’s Board of Directors. A copy of the news release is filed as Exhibit 99.1 to this report and incorporated herein by reference.

Item 9.01.

Financial Statements and Exhibits.

(d)

Exhibits.

99.1 News Release, dated July 12, 2007, regarding the record date for the spin-offs of Registrant’s and Kindred’s institutional pharmacy businesses and the members of the Board of Directors of the new company.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.